Running Through Walls podcast

Under Promise, Over Deliver

0:00
37:59
Retroceder 15 segundos
Avanzar 15 segundos

Venrock partners Andrew Gottesdiener and Nimish Shah sat down with Michael Henderson, CEO of Apogee Therapeutics, to talk about selling Apogee to AbbVie for nearly $11 billion, the hardest part of being a CEO, what it takes to build a great team and culture, Michael's three rules for first-time biotech CEOs, and more.

Otros episodios de "Running Through Walls"